TP53 and neoplasm: Coding mutations in TP53 had a high likelihood of being clonal and thus occurring early in tumor progression, consistent with it being a known driver event in basal breast cancer, as well as preceding whole-genome duplication consistent with TP53 function and recent findings from single-cell, single-molecule DNA sequencing (DNA-seq) of eight human TNBCs and four cell lines.18